ZEALAND PHARMA A/S: Financial statements 2019
CVR: 20045078
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
ZEALAND PHARMA A/S (CVR 20045078) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK 41,333,000 and a net result of DKK -571,541,000 compared with DKK 581,282,000 the year before. That is an increase of 8.8% compared with the year before. The profit margin was -1,382.8%. Equity in the 2019 report amounted to DKK 1,242,673,000. The solvency ratio was 77.7%.
- Revenue
- DKK 41,333,000
- Profit/Loss
- DKK -571,541,000
- Equity
- DKK 1,242,673,000
- Total Assets
- DKK 1,599,514,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | 41.3M | - | -571.5M | 1.2B | - |
| 2018 | 38M | - | 581.3M | 1.1B | - |
| 2017 | 139.8M | - | -272.3M | 528.5M | - |
| 2016 | 234.8M | - | -153.9M | 278.2M | - |
| 2015 | 187.7M | 165.4M | -114M | 252.2M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of October 25, 2019, Matthew Donald Dallas is registered as director of ZEALAND PHARMA A/S.
ZEALAND PHARMA A/S has published its annual report for 2018. Revenue came to DKK 37,977,000, and the net result was DKK 581,282,000.
As of April 22, 2019, Adam Sinding Steensberg is registered as director of ZEALAND PHARMA A/S.
As of April 22, 2019, Emmanuel Dulac is registered as adm. dir. of ZEALAND PHARMA A/S.
As of April 22, 2019, Emmanuel Dulac is registered as adm. dir. of ZEALAND PHARMA A/S.
As of April 22, 2019, Emmanuel Dulac has stepped down as adm. dir. of ZEALAND PHARMA A/S.
As of April 21, 2019, Adam Sinding Steensberg has stepped down as adm. dir. of ZEALAND PHARMA A/S.
As of April 4, 2019, Kirsten Aarup Drejer has joined the board of directors of ZEALAND PHARMA A/S.
As of April 4, 2019, Jeffrey Berkowitz has joined the board of directors of ZEALAND PHARMA A/S.
As of April 4, 2019, Leonard Kruimer has joined the board of directors of ZEALAND PHARMA A/S.
About ZEALAND PHARMA A/S
ZEALAND PHARMA A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 1997. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ZEALAND PHARMACEUTICALS A/S and PEPTIDE PROBE TECHNOLOGIES ApS. The management consists of Adam Sinding Steensberg and Henriette Wennicke. The board consists of Alf Gunnar Martin Nicklasson (chair), Kirsten Aarup Drejer, Adam Krisko Nygaard and Anneline Nansen. The company's owners include ZEALAND PHARMA A/S, Van Herk Investments B.V. and Van Herk Management Services B.V.. The company has 575 employees (2026). In 2025, the company reported revenue of DKK 9,214,860,000 and a net result of DKK 6,455,008,000 compared with DKK -1,078,828,000 the year before. Equity in the 2025 report amounted to DKK 14,830,613,000.
